ELEKTA AB/ADR (EKTAY) Reaches New 52-Week Low at $10.98

ELEKTA AB/ADR (OTCMKTS:EKTAY)’s share price hit a new 52-week low on Monday . The stock traded as low as $10.98 and last traded at $10.98, with a volume of 1030 shares trading hands. The stock had previously closed at $11.10.

Several equities research analysts recently issued reports on EKTAY shares. Zacks Investment Research upgraded ELEKTA AB/ADR from a “sell” rating to a “hold” rating in a report on Wednesday, April 10th. ValuEngine cut ELEKTA AB/ADR from a “buy” rating to a “hold” rating in a report on Tuesday, April 9th.

The company has a debt-to-equity ratio of 0.62, a current ratio of 1.18 and a quick ratio of 0.93. The firm has a market capitalization of $4.05 billion, a PE ratio of 31.40, a PEG ratio of 2.26 and a beta of 0.49.

ELEKTA AB/ADR (OTCMKTS:EKTAY) last posted its quarterly earnings data on Friday, February 22nd. The company reported $0.06 earnings per share (EPS) for the quarter. ELEKTA AB/ADR had a return on equity of 16.86% and a net margin of 9.35%. The company had revenue of $367.04 million for the quarter. On average, research analysts expect that ELEKTA AB/ADR will post 0.35 EPS for the current year.

TRADEMARK VIOLATION WARNING: “ELEKTA AB/ADR (EKTAY) Reaches New 52-Week Low at $10.98” was originally published by Baseball Daily News and is owned by of Baseball Daily News. If you are accessing this article on another domain, it was stolen and republished in violation of US & international copyright law. The correct version of this article can be viewed at https://www.baseballdailydigest.com/news/2019/05/20/elekta-ab-adr-ektay-reaches-new-52-week-low-at-10-98.html.


Elekta AB (publ) provides equipment and software for cancer and brain disorders worldwide. The company offers radiotherapy systems under the Versa HD, Precise Treatment System, and Elekta Compact names; Elekta Infinity, an image-guided radiation therapy (IGRT) system; and Elekta Synergy, a digital accelerator for advanced IGRT.

Featured Story: Using the New Google Finance Tool

Receive News & Ratings for ELEKTA AB/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ELEKTA AB/ADR and related companies with MarketBeat.com's FREE daily email newsletter.